loadpatents
name:-0.013885974884033
name:-0.011327028274536
name:-0.0013890266418457
Houghton; Alan N. Patent Filings

Houghton; Alan N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Houghton; Alan N..The latest application filed is for "method and compositions for stimulation of an immune response to gp100 using a xenogeneic gp100 antigen".

Company Profile
0.10.10
  • Houghton; Alan N. - New York NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method and Compositions for Stimulation of an Immune Response to TRP2 using a Xenogeneic TRP2 Antigen
App 20100068263 - Houghton; Alan N. ;   et al.
2010-03-18
Method and Compositions for Stimulation of an Immune Response to PSMA using a Xenogeneic PSMA Antigen
App 20100068262 - Houghton; Alan N. ;   et al.
2010-03-18
Method and Compositions for Stimulation of an Immune Response to gp100 using a Xenogeneic gp100 Antigen
App 20100068216 - Houghton; Alan N. ;   et al.
2010-03-18
Compositions for treatment of melanoma and method of using same
Grant 7,556,805 - Houghton , et al. July 7, 2
2009-07-07
GP75 as a tumor vaccine for melanoma
App 20050037462 - Houghton, Alan N. ;   et al.
2005-02-17
Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
Grant 6,805,862 - Chapman , et al. October 19, 2
2004-10-19
Method for identification of mutant antigens with enhanced immunogenicity
App 20030224392 - Engelhorn, Manuel ;   et al.
2003-12-04
DNA immunization with libraries of minigenes encoding degenerate variants of major histocompatability class l restricted epitopes
App 20030157534 - Engelhorn, Manuel ;   et al.
2003-08-21
Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
App 20030035797 - Chapman, Paul B. ;   et al.
2003-02-20
Cell lines and vectors for stimulation of an immune response to a differentiation antigen stimulated by an altered antigen
App 20020164318 - Houghton, Alan N. ;   et al.
2002-11-07
Method for stimulation of an immune response to a differentiation antigen stimulated by an altered antigen
App 20020155093 - Houghton, Alan N. ;   et al.
2002-10-24
Compositions for treatment of melanoma and method of using same
App 20020150589 - Houghton, Alan N. ;   et al.
2002-10-17
Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen
Grant 6,328,969 - Houghton , et al. December 11, 2
2001-12-11
Anti-idiotypic antibody vaccines
Grant 5,792,455 - Chapman , et al. August 11, 1
1998-08-11
Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD.sub.3 and hybridoma producing said antibody
Grant 5,529,922 - Chapman , et al. June 25, 1
1996-06-25
Human monoclonal antibodies to cell surface antigens
Grant 4,695,538 - Cote , et al. September 22, 1
1987-09-22
Human monoclonal antibodies from lymphocytes of patients with malignant melanoma
Grant 4,693,966 - Houghton , et al. September 15, 1
1987-09-15
Cell surface antigens of human astrocytoma
Grant 4,642,291 - Cairncross , et al. February 10, 1
1987-02-10
Human monoclonal antibodies to cancer cells
Grant 4,613,576 - Cote , et al. September 23, 1
1986-09-23
Melanoma tumor antigen and autologous antibody
Grant 4,562,160 - Real , et al. December 31, 1
1985-12-31
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed